Bioharvest Sciences (BHST) Cash from Financing Activities (2023 - 2025)
Bioharvest Sciences has reported Cash from Financing Activities over the past 3 years, most recently at $14.9 million for Q4 2025.
- For Q4 2025, Cash from Financing Activities rose 508.92% year-over-year to $14.9 million; the TTM value through Dec 2025 reached $30.2 million, up 345.24%, while the annual FY2025 figure was $30.2 million, 345.24% up from the prior year.
- Cash from Financing Activities was $14.9 million for Q4 2025 at Bioharvest Sciences, up from $9.7 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $14.9 million in Q4 2025 and bottomed at -$164000.0 in Q3 2024.
- The 3-year median for Cash from Financing Activities is $2.8 million (2024), against an average of $4.5 million.
- Year-over-year, Cash from Financing Activities tumbled 113.86% in 2024 and then soared 6036.59% in 2025.
- Over 3 years, Cash from Financing Activities stood at $7.0 million in 2023, then tumbled by 64.99% to $2.5 million in 2024, then skyrocketed by 508.92% to $14.9 million in 2025.
- The last three reported values for Cash from Financing Activities were $14.9 million (Q4 2025), $9.7 million (Q3 2025), and $2.4 million (Q2 2025) per Business Quant data.